When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Microcurrent electrical neuromuscular stimulator - Wikipedia

   en.wikipedia.org/wiki/Microcurrent_electrical...

   A study by a neuroretinologist in the late 1980s suggested that microcurrent stimulation of acupuncture points for the eye had positive effects in slowing and even stopping progression of macular degeneration. [citation needed] This treatment is used to treat both the Wet and Dry forms of AMD. This study was based on Ngok Cheng's research on ...

3. Lineage Cell Therapeutics - Wikipedia

   en.wikipedia.org/wiki/Lineage_Cell_Therapeutics

   Lineage is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. The company changed its name from BioTime Inc. to Lineage Cell Therapeutics less than one year following its appointment of a new CEO, Brian Culley, in August 2018 and completing a series of corporate transactions including the distribution of AgeX Therapeutics, the acquisition of ...

4. Pegaptanib - Wikipedia

   en.wikipedia.org/wiki/Pegaptanib

   Pegaptanib [2] sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). [3] It was discovered by NeXstar Pharmaceuticals (which merged with Gilead Sciences in 1999) and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States.

5. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

   www.aol.com/fda-approves-biosimilars-macular...

   These drugs are approved to treat neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy. View the ...

6. Ranibizumab - Wikipedia

   en.wikipedia.org/wiki/Ranibizumab

   Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.

7. 40 mice will be sent to space to help with macular ... - AOL

   www.aol.com/40-mice-sent-space-help-184155536.html

   For patients suffering from macular degeneration in the intermediate stage and advanced stages, this takes away people’s ability to read their own medications, do their own finances and their ...